Our website uses cookies to ensure you get the best experience with the most relevant info provided

Our mission

is to serve greater longevity and prevent heart disorders for elevated heart risk groups through innovative and clinically proven predictive algorithms


The ultimate vision we have is to be an essential part of the population's health monitoring and heart disease prevention systems, providing the best prognostic tools for managing heart health and leading the prediction of cardiovascular diseases (CVD), chronic fatigue, and burnout.


We act on values of Health Sustainability, Innovation, Reliability, and Collaboration to globally improve people's heart health.


Anna Starynska

Chief Executive Officer

Has MS in Computer & Data Science and is an impeccable project manager with more than 25 years of experience in leading multinational complex projects, such as the European Commission initiative for the 15 Nuclear Power Plants maintenance optimization and the Global Tuberculosis Fund projects management. She is a natural leader, truly passionate about improving heart health, and a serial entrepreneur who bootstrapped the company with her life savings.

Read more

Illya Chaikovsky

Chief Science Officer

MD, multiple Ph.D. with more than 30 years of practicing in cardiology. He's the globally-renowned scientist, whose invaluable experience gained at the Institute of Cybernetics, the Ukrainian Academy of Science, his German Radgein University Ph.D. work, and multiple pieces of research form the core of Cardiolyse CE-certified ECG processing algorithms and patents. Illya is leading an advisory council of PhDs in Cardiology, Cybernetics, Neural Networks, and Data Science, that together with the development team are constantly improving and further clinically validating our algorithms.

Read more



Company launch


First algorithms finalized and web-platform developed


Oxford University and China Kadoorie Biobank ongoing validation project start


Patents for Method of ECG Evaluation Based on Universal ECG Scoring System filed


The ongoing pilot on CVD remote heart health monitoring in India starts


Fatigue Risk Management proof of concept for liability insurance launched


Company brand update, Heart Health monitoring Android and iOS app update

Stay tuned for our news



CE certification
SX 60145511 0001 class 2a


Top-10 Ukrainian-UK startup contest winner


Top-100 Startups at Slush, Finland


Alumni of Startupbootcamp Digital Health, Berlin


Seal of Excellence certificate from European Commission


GE Healthcare Innovation Village Resident


Selected participant of Novartis HealthTech Lab at Vivatech


Selected participant at TechCrunch SF


We've successfully raised €600К+ for Cardiolyse’s initial platform development, market research, and clinical trials, along with the first successful pilots with the world's key players from the insurance and pharma sectors, hospital inpatient and outpatient units.

Read more

Cardiolyse has opened its last seed investment round now to grow exponentially, conduct cardiovascular disease prevention researches of global value, maintain further clinical trials and develop next product features of patients' and healthcare providers' value while enhancing our team with the robust talent to tackle emerging challenges and obtaining certifications for the next markets entry.

Find out more about Cardiolyse investment opportunities
to join the healthcare digital transformation movement and leave your lasting footprint in cardio diagnostics advancement

Let’s work together
on heart health improvement